Use of Morphological Index as a Drug Resistance Marker in Leprosy: Challenges and Considerations.
作者信息
Pawar Harpreet Singh, Sagar Harish Kumar
机构信息
From the Department of Clinical Medicine, Clinical Division, ICMR- National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh, India E-mail:
出版信息
Indian J Dermatol. 2025 Sep-Oct;70(5):300. doi: 10.4103/ijd.ijd_582_24. Epub 2025 Sep 1.
Abstract
摘要
相似文献
1
Use of Morphological Index as a Drug Resistance Marker in Leprosy: Challenges and Considerations.将形态学指标用作麻风病耐药性标志物：挑战与考量
Indian J Dermatol. 2025 Sep-Oct;70(5):300. doi: 10.4103/ijd.ijd_582_24. Epub 2025 Sep 1.
2
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性：受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
3
Efficacy of leprosy vaccines across the globe: A systematic review & meta-analysis of randomized controlled trials.全球麻风病疫苗的疗效：随机对照试验的系统评价与荟萃分析
Indian J Med Res. 2024;160(3&4):293-302. doi: 10.25259/IJMR_1289_2024.
5
Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.利福平化学预防在预防麻风病患者接触者感染方面的有效性：对定量和定性证据的系统评价
JBI Database System Rev Implement Rep. 2017 Oct;15(10):2555-2584. doi: 10.11124/JBISRIR-2016-003301.
6
Leprosy serology using PGL-I: a systematic review.使用酚糖脂-I的麻风血清学：一项系统评价
Rev Soc Bras Med Trop. 2008;41 Suppl 2:11-8. doi: 10.1590/s0037-86822008000700004.
7
Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care.生物标志物作为即时检验手段，用于指导基层医疗中急性呼吸道感染患者的抗生素处方。
Cochrane Database Syst Rev. 2014 Nov 6(11):CD010130. doi: 10.1002/14651858.CD010130.pub2.
8
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.生物标志物作为即时检测手段，指导初级保健中急性呼吸道感染患者使用抗生素的处方。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.
9
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.耐药性（氨苯砜、利福平、氧氟沙星）与麻风病患者耐药相关基因突变特征：系统评价和荟萃分析。
Int J Mol Sci. 2022 Oct 18;23(20):12443. doi: 10.3390/ijms232012443.
10
Risk factors and leprosy incidence among contacts in Bangladesh: A multilevel analysis.孟加拉国接触者中的危险因素与麻风发病率：一项多层次分析。
PLoS Negl Trop Dis. 2025 Sep 5;19(9):e0013465. doi: 10.1371/journal.pntd.0013465. eCollection 2025 Sep.
本文引用的文献
1
Morphological Index as a Sensitive Marker of Drug Resistance in Leprosy: A Case Series.形态学指标作为麻风病耐药性的敏感标志物：病例系列研究
Indian J Dermatol. 2024 Mar-Apr;69(2):202. doi: 10.4103/ijd.ijd_781_23. Epub 2024 Apr 29.
2
Slit-skin smear in leprosy: lest we forget it!麻风病中的 slit-skin 涂片：我们切莫忘记它！ （注：“slit-skin smear”可能是特定医学术语，直译为“ slit-skin涂片”，具体准确含义可能需结合专业医学知识进一步明确）
Indian J Lepr. 2013 Oct-Dec;85(4):177-83.
3
Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria.多菌型麻风的复发与反应：新复发标准的提议
Trop Med Int Health. 2008 Mar;13(3):295-309. doi: 10.1111/j.1365-3156.2008.02003.x.
4
Relapses in multibacillary leprosy patients: effect of length of therapy.
Lepr Rev. 2000 Jun;71(2):144-53. doi: 10.5935/0305-7518.20000017.
Zotero 插件